What does CUSIP 04272N102 represent in this 13F holders report?

CUSIP 04272N102 is the security identifier for AVBP - ArriVent BioPharma, Inc. - Common Stock used to aggregate holder disclosures.

How many institutions held AVBP - ArriVent BioPharma, Inc. - Common Stock in Q1 2026?

138 institutional investors reported AVBP - ArriVent BioPharma, Inc. - Common Stock for Q1 2026. Use the holders table for investor-level position and value details.

ArriVent BioPharma, Inc. - Common Stock (AVBP)

CUSIP: 04272N102

Q1 2026 13F Holders as of 31 Mar 2026

Security type / class: Equity / Common Stock
Total 13F shares: 42,089,344
Total 13F value: $969,468,905
Share change: +1,675,713
Put/Call ratio: 23%
SEC-reported price per share: $23.07
Number of holders: 138
Value change: +$42,325,450
Number of buys: 84
Number of sells: 44
Shares outstanding: 46,795,294

Security key

04272N102

Report period

Q1 2026

Institutions

138

Top holders

AVBP full security history Ownership snapshot Full 13F holder table Newer quarter: Q2 2026 ArriVent BioPharma, Inc. SEC filings ArriVent BioPharma, Inc. company facts

Broader feeds

Latest 13F filings Latest 13D/G filings Investors directory

Reporting periods

Holder history for CUSIP 04272N102

Newer quarter: Q2 2026

Recent filing periods:

Q2 2026

Ownership snapshot

Top reported holders of AVBP - ArriVent BioPharma, Inc. - Common Stock (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader

INFINITUM ASSET MANAGEMEN...

Disclosed value leader

HILLHOUSE INVESTMENT MANA...

Comparable rows

15/15

Latest evidence

31 Mar 2026

13D/G 13F 3/4/5 Lead comparable stake: 9.9% 13D/G row: INFINITUM ASSET MANAGEMENT, LLC Showing 1-6 of 15 holder rows.

Quick read

INFINITUM ASSET MANAGEMENT, LLC leads the comparable SEC ownership view at 9.9%.

15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens INFINITUM ASSET MANAGEMENT, LLC's linked filing trail.

Comparable ownership Top 5

INFINITUM ASSET MANAGEMENT, LLC 9.9%

SUVRETTA CAPITAL MANAGEMENT, LLC 9.9%

HILLHOUSE INVESTMENT MANAGEMENT, ... 9.5%

ORBIMED ADVISORS LLC 7.5%

FMR LLC 6.8%

Ownership % is shown only when SEC disclosures are safely comparable across share classes.

Detailed SEC evidence table Showing 1-6 of 15 holder rows

Holder	Evidence	Ownership %	Position	12M Net Δ	As of
INFINITUM ASSET MANAGEMENT, LLC	13D/G 13F Company 13D/G 13F	9.9%	$90,602,588 4,123,923 shares	+$15,488,850	31 Dec 2025
SUVRETTA CAPITAL MANAGEMENT, LLC	13F 13D/G Company 13F 13D/G	9.9% from 13D/G	$82,613,424 4,106,035 shares	—	31 Dec 2025
HILLHOUSE INVESTMENT MANAGEMENT, LTD.	3/4/5 13D/G 10%+ Owner 3/4/5 13D/G	9.5% from 13D/G	$91,823,464 3,929,117 shares	-$12,983,320	10 Dec 2025
ORBIMED ADVISORS LLC	13D/G 3/4/5 13F Director, 10%+ Owner · Company 13D/G 3/4/5 13F	7.5%	$66,692,036 3,027,328 shares	$0	11 Aug 2025
FMR LLC	13D/G 13F Company 13D/G 13F	6.8%	$82,189,593 3,016,132 shares	-$10,666,113	31 Mar 2026
HBM Healthcare Investments (Cayman) Ltd.	13D/G 13D/G	5.4%	$40,491,643 2,195,014 shares	$0	08 Oct 2025

How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q1 2026

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions

138

42,089,344

Rows available

138

Investor	Option	Weight %	Change %	SEC-reported value	* Price	Shares	Share Change	Activity	Report Period

^* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q1 2026 vs Q1 2026 Across Filers

Q1 2026 holders

138

Q1 2026 holders

138

Holder diff

Investor	Q1 2026 Shares	Q1 2026 Shares	Share Diff	Share Chg %	Q1 2026 value	Q1 2026 value	Value change	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend